Published in Transplantation on April 27, 2003
Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience. Ann Surg (2006) 1.43
Biliary atresia. Orphanet J Rare Dis (2006) 0.92
Pediatric liver transplantation. World J Gastroenterol (2009) 0.92
One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: lessons learned and outlook for the future. Ann Surg (2004) 0.91
Living donor liver transplantation. HPB (Oxford) (2006) 0.82
Small-for-Size Liver Transplantation Increases Pulmonary Injury in Rats: Prevention by NIM811. HPB Surg (2012) 0.77
Outcomes in adult recipients of right-sided liver grafts in split-liver procedures. HPB (Oxford) (2010) 0.75
Living donor liver transplantation: eliminating the wait for death in end-stage liver disease? Nat Rev Gastroenterol Hepatol (2017) 0.75
Outcomes of Technical Variant Liver Transplantation versus Whole Liver Transplantation for Pediatric Patients: A Meta-Analysis. PLoS One (2015) 0.75
Surgical experience in splitting donor liver into left lateral and right extended lobes. World J Gastroenterol (2005) 0.75
Living donor liver transplantation in Europe. Hepatobiliary Surg Nutr (2016) 0.75
Transplantation: Partial liver grafts are safe for young children. Nat Rev Gastroenterol Hepatol (2013) 0.75
Outcomes of Full-Right-Full-Left Split Liver Transplantation in Adults in the USA: A Propensity-Score Matched Analysis. Int J Organ Transplant Med (2016) 0.75
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood (2005) 6.07
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet (2003) 3.07
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. Haematologica (2006) 2.54
Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major. Haematologica (2006) 2.14
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Eur J Haematol (2007) 2.14
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up. Haematologica (2008) 2.12
Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia. Haematologica (2003) 1.94
Cranioectodermal Dysplasia, Sensenbrenner syndrome, is a ciliopathy caused by mutations in the IFT122 gene. Am J Hum Genet (2010) 1.86
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol (2007) 1.77
Preemptive liver transplantation in a child with familial hypercholesterolemia. Pediatr Transplant (2010) 1.71
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. Hepatology (2013) 1.65
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Feasibility and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in children. J Pediatr Gastroenterol Nutr (2012) 1.55
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54
Surgical management of complex liver trauma: a single liver transplant center experience. Am Surg (2012) 1.53
Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol (2004) 1.53
Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. J Clin Pharmacol (2003) 1.46
Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation. Transplantation (2008) 1.46
Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience. Ann Surg (2006) 1.43
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver. Blood (2010) 1.40
Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging. Haematologica (2010) 1.31
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol (2007) 1.26
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24
Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation. Am J Transplant (2005) 1.23
Gastric duplication associated with pancreas divisum diagnosed by a multidisciplinary approach before surgery. World J Gastroenterol (2010) 1.22
Development of tridentate iron chelators: from desferrithiocin to ICL670. Curr Med Chem (2003) 1.21
Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients. Clin Cancer Res (2003) 1.19
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica (2008) 1.18
Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome. Transplantation (2002) 1.15
Retrospective study of 111 cases of congenital diaphragmatic hernia treated with early high-frequency oscillatory ventilation and presurgical stabilization. J Pediatr Surg (2007) 1.11
Idiopathic central diabetes insipidus is associated with abnormal blood supply to the posterior pituitary gland caused by vascular impairment of the inferior hypophyseal artery system. J Clin Endocrinol Metab (2004) 1.10
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia. Blood (2004) 1.09
MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapy. Brain (2013) 1.07
Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). Eur J Haematol (2007) 1.07
Overweight and Pediatric Inflammatory Disease: Is It a True Association? J Pediatr Gastroenterol Nutr (2015) 1.06
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up. Haematologica (2009) 1.05
Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. Transl Res (2010) 1.02
Efficient human fetal liver cell isolation protocol based on vascular perfusion for liver cell-based therapy and case report on cell transplantation. Liver Transpl (2012) 1.00
Dihydropteridine reductase deficiency in man: from biology to treatment. Med Res Rev (2004) 0.98
Clinical and genetic characterization of Chanarin-Dorfman syndrome. Biochem Biophys Res Commun (2008) 0.97
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study. PLoS One (2013) 0.97
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. Hepatology (2011) 0.96
Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation (2008) 0.96
Causes, coping, and culture: a comparative survey study on representation of back pain in three Swiss language regions. PLoS One (2013) 0.96
Meso-Rex bypass as an alternative technique for portal vein reconstruction at or after liver transplantation in children: review and perspectives. Pediatr Transplant (2012) 0.96
Split and whole liver transplantation outcomes: a comparative cohort study. Liver Transpl (2006) 0.95
Plasma citrulline as surrogate marker of intestinal inflammation in pediatric and adolescent with Crohn's disease: preliminary report. Int J Colorectal Dis (2011) 0.92
Pediatric liver transplantation. World J Gastroenterol (2009) 0.92
Early regeneration of the remnant liver volume after right hepatectomy for living donation: a multiple regression analysis. Liver Transpl (2012) 0.91
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia. Blood (2003) 0.91
Sensenbrenner syndrome: a new member of the hepatorenal fibrocystic family. Am J Med Genet A (2006) 0.90
Monogenic diseases that can be cured by liver transplantation. J Hepatol (2013) 0.90
Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria. Transpl Int (2008) 0.90
Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes. World J Gastroenterol (2009) 0.89
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. BMC Gastroenterol (2012) 0.89
Linking quality-of-life measures using the International Classification of Functioning, Disability and Health and the International Classification of Functioning, Disability and Health-Children and Youth Version in chronic health conditions: the example of young people with hemophilia. Am J Phys Med Rehabil (2012) 0.89
A new Caucasian case of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD): a clinical, molecular, and functional study. Mol Genet Metab (2011) 0.89
Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimen. J Clin Pharmacol (2008) 0.88
Completely obstructed colorectal anastomosis: a new non-electrosurgical endoscopic approach before balloon dilatation. World J Gastroenterol (2010) 0.88
Biliary dilatation secondary to lithiasis in a child affected by Langerhans' cell histiocytosis. J Clin Ultrasound (2009) 0.87
Zidovudine administration during pregnancy and mitochondrial disease in the offspring. Antivir Ther (2005) 0.87
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience. Transplantation (2013) 0.87
Clinical performance of NICE recommendations versus NCWFNS proposal in patients with mild head injury. J Neurotrauma (2005) 0.87
The role of the robotic technique in minimally invasive surgery in rectal cancer. Ecancermedicalscience (2013) 0.85
Right hepatic lobe living donation: a 12 years single Italian center experience. World J Gastroenterol (2013) 0.85
Phalangeal quantitative ultrasound in children with phenylketonuria: a pilot study. Ultrasound Med Biol (2008) 0.85
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transpl (2010) 0.85
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. BMC Gastroenterol (2012) 0.85
Impact of blood transfusion on early outcome of liver resection for colorectal hepatic metastases. J Surg Oncol (2010) 0.84
Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders. Mol Genet Metab (2004) 0.84
A positive blood alcohol concentration is the main predictor of recurrent motor vehicle crash. Ann Emerg Med (2005) 0.84
Identification of nine new IDS alleles in mucopolysaccharidosis II. Quantitative evaluation by real-time RT-PCR of mRNAs sensitive to nonsense-mediated and nonstop decay mechanisms. Biochim Biophys Acta (2006) 0.84
On-line monitoring of lung mechanics during spontaneous breathing: a physiological study. Respir Med (2010) 0.83
Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase. PLoS One (2010) 0.83
Tulip bundle technique and fibrin glue injection: unusual treatment of colonic perforation. World J Gastroenterol (2011) 0.83
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry. Transpl Int (2006) 0.83
Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience. Liver Transpl (2006) 0.82
Impact of metabolic control on bone quality in phenylketonuria and mild hyperphenylalaninemia. J Pediatr Gastroenterol Nutr (2011) 0.82
Impact of recipients' socio-economic status on patient and graft survival after liver transplantation: the IsMeTT experience. Dig Liver Dis (2011) 0.82
Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study. Antivir Ther (2007) 0.82
A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency. Ital J Pediatr (2013) 0.82
Steatosis and fibrosis in paediatric liver transplant: insidious graft's enemies--a call for clinical studies and research. Pediatr Transplant (2010) 0.82
Percutaneous management of biliary strictures after pediatric liver transplantation. Cardiovasc Intervent Radiol (2008) 0.81
Newborn screening for galactosemia: a 30-year single center experience. World J Pediatr (2015) 0.81